Introduction to 5-MAPB 100mg (Substituted Benzofuran)

5-MAPB, biochemically designated as 1-(1-benzofuran-5-yl)-N-methylpropan-2-amine, is a synthetic substituted benzofuran compound under intense examination within behavioral neuroscience, neurochemistry, and psychopharmacology. Structurally analogous to 3,4-methylenedioxymethamphetamine (MDMA), 5-MAPB replaces the core ring-substituted methylenedioxy system with a distinct benzofuran heterocyclic core. This conformational alteration significantly shifts its binding affinity across central monoamine transporters, making it an essential molecular probe for mapping monoaminergic neurotransmission, structural transporter transitions, and cell-autonomous signal transduction in mammalian laboratory models.

In native biological systems, standard phenethylamine molecules are highly susceptible to immediate metabolic deamination by localized monoamine oxidase enzymes. To enable long-term pharmacokinetic evaluations across varying cellular microenvironments and stabilize the molecule against rapid enzymatic cleavage, 5-MAPB features a protective benzofuran ring structure. At ULTRA RAWZ, we distribute this foundational neurochemical sequence as a premium 100mg encapsulated reference standard, providing molecular biology and pathology research institutions with an absolute baseline reagent for mapping transporter-specific recovery curves.

Molecular Profile and Structural Specifications

To ensure experiment reproducibility and absolute laboratory traceability, researchers must evaluate 5-MAPB using its exact chemical identifiers and thermodynamic metrics:

• Systematic IUPAC Name: 1-(1-benzofuran-5-yl)-N-methylpropan-2-amine

• CAS Registry Number: 1354631-77-8 (Free Base) | 1823925-53-6 (Hydrochloride Salt)

• Molecular Formula: C12H15NO (Free Base) | C12H16ClNO (HCl Salt)

• Molecular Weight (MW): 189.25 g/mol (Free Base) | 225.71 g/mol (HCl Salt)

• Chemical Classification: Substituted Phenethylamine (Benzofuran Variant)

Research Overview: Transporter Substrate Dynamics and Receptor Kinetics

The primary scientific value of 5-MAPB 100mg centers on its capability to trigger neurotransmitter efflux programs by modulating specific monoamine transport loops and receptor pathways. By operating as a high-potency triple monoamine reuptake inhibitor and releasing agent, this compound allows researchers to isolate cell-autonomous monoamine release mechanisms under controlled laboratory conditions.

Key areas of active scientific investigation utilizing 5-MAPB 100mg include:

• Serotonin Transporter (SERT) Mediated Efflux: Analyzing the cellular transport dynamics involved in high-volume extracellular serotonin accumulation. Researchers utilize 5-MAPB to track the competitive binding kinetics at the SERT site, mapping how the compound reverses standard transport direction to simulate entactogenic baseline profiles in animal models.

• Dopamine Transporter (DAT) Reversal Kinematics: Investigating the activation of central reward pathway cascades. 5-MAPB is heavily studied for its capacity to augment the area under the curve for dopamine efflux. Researchers monitor how this specific benzofuran backbone interfaces with DAT to drive reverse transport without causing the rapid cellular exhaustion associated with traditional neurotoxic amphetamines.

• Norepinephrine Transporter (NET) Inhibition and Sympathetic Signaling: Evaluating the regulation of vascular endothelium and sympathetic nervous system tone. Researchers analyze 5-MAPB interaction with NET to observe how the compound stabilizes extracellular norepinephrine levels, providing data on homeostatic cardiac stress modeling and central alertness pathways.

• Serotonin Receptor Subunit Partial Agonism: Tracking how the compound interacts with secondary binding targets. Beyond its prominent status in transporter clearance assays, radioligand binding studies demonstrate that 5-MAPB exhibits selective affinity as a partial agonist at the 5-HT2A, 5-HT2B, and 5-HT2C receptors, as well as a potent agonist at the 5-HT1A and 5-HT1B lines, helping to map localized neuro-endocrine modulation loops.

Quality Standards & Analytical Testing

At ULTRA RAWZ, laboratory data integrity and compound reproducibility are the fundamental core of our manufacturing operations. Every single production lot of 5-MAPB 100mg Capsules undergoes a strict quality control validation protocol to eliminate compounding variables and experimental artifacts. We utilize High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS) to confirm an absolute chemical purity profile of 99% or greater for the active matrix before encapsulation. This rigorous analytical validation verifies the exact molecular composition, precise weight, and correct spatial conformation while ensuring the total absence of residual synthesis reagents, truncated fragments, heavy metals, or raw contaminants. A batch-specific Certificate of Analysis (COA) accompanies every order to guarantee absolute reproducibility.

Storage, Solubility, and Handling Requirements

As a purified crystalline hydrochloride salt enclosed in protective capsules, 5-MAPB HCl possesses robust thermal stability compared to volatile free-base amines. However, to maintain absolute chemical integrity and prevent premature oxidation, the compound must be stored long-term in a freezer environment at -20°C, completely shielded from ambient light, heat, and internal humidity.

For in vitro reconstitution and assay alignment, 5-MAPB HCl exhibits high solubility profiles across standard laboratory solvents. It dissolves fully in dimethyl sulfoxide (DMSO) at 25 mg/ml, dimethylformamide (DMF) at 25 mg/ml, and phosphate-buffered saline (PBS, pH 7.2) at 10 mg/ml. Reconstituted solution matrices are highly vulnerable to accelerated hydrolytic degradation and must be utilized immediately or stored in aliquots under strict refrigeration (2°C to 8°C) for no longer than 24 hours. Researchers must handle the compound with appropriate personal protective equipment to prevent any accidental exposure.

Research Use Disclaimer

The compounds distributed by ULTRA RAWZ, including 5-MAPB 100mg research capsules, are designated strictly for laboratory research purposes only. Under no circumstances are these products approved or intended for human or veterinary consumption, direct clinical diagnostics, or therapeutic drug administration. All handling, measuring, and experimental evaluation must be conducted exclusively by qualified scientific professionals within a certified and monitored research facility.

People Also Ask: 5-MAPB Research Frequently Asked Questions

What is 5-MAPB and how does it function in laboratory research?

5-MAPB is a synthetic substituted benzofuran compound studied as a triple monoamine releasing agent. In laboratory research, it functions as a substrate for serotonin, dopamine, and norepinephrine transporters, reversing transport flow to increase extracellular monoamine levels for neurochemical modeling.

What is the difference between 5-MAPB and MDMA in chemical structure?

While both share a phenethylamine backbone, 5-MAPB replaces the methylenedioxy ring structure found in MDMA with a benzofuran ring. This structural shift alters its binding profile, rendering 5-MAPB a highly potent monoamine releaser with distinct serotonin receptor subunit affinities.

What are the optimal solubility specifications for 5-MAPB HCl?

5-MAPB HCl is highly soluble in polar organic solvents and aqueous buffers. Optimal laboratory dissolution is achieved in DMSO or DMF at 25 mg/ml, as well as phosphate-buffered saline (PBS, pH 7.2) at a stability baseline of 10 mg/ml.

How should 5-MAPB capsules be stored to ensure long-term stability?

To prevent oxidative and hydrolytic breakdown, 5-MAPB capsules must be stored in a cool, dry environment at or below -20°C. Keep the container vacuum-sealed with an active desiccant and completely shielded from direct light exposure.